These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 4169043)

  • 1. Dose-dependence of drug plasma level decline in dogs.
    Dayton PG; Cucinell SA; Weiss M; Perel JM
    J Pharmacol Exp Ther; 1967 Nov; 158(2):305-16. PubMed ID: 4169043
    [No Abstract]   [Full Text] [Related]  

  • 2. Physiological and physicochemical bases of drug interactions in man.
    Dayton PG; Perel JM
    Ann N Y Acad Sci; 1971 Jul; 179():67-87. PubMed ID: 4105795
    [No Abstract]   [Full Text] [Related]  

  • 3. An experimental model in dogs for studying interactions of drugs with bishydroxycoumarin.
    Welch RM; Harrison YE; Conney AH; Burns JJ
    Clin Pharmacol Ther; 1969; 10(6):817-25. PubMed ID: 4186901
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of phenobarbital or SKF 525A pretreatment on diphenylhydantoin disposition in pregnant mice.
    Harbison RD; Becker BA
    Toxicol Appl Pharmacol; 1971 Dec; 20(4):573-81. PubMed ID: 5143597
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of phenylbutazone on the distribution, elimination and anticoagulant action of dicumarol in rats.
    Jähnchen E; Wingard LB; Levy G
    J Pharmacol Exp Ther; 1973 Oct; 187(1):176-84. PubMed ID: 4126886
    [No Abstract]   [Full Text] [Related]  

  • 6. IV. Pharmacogenetics and drug toxicity. Variation of drug metabolism in animals and the prediction of drug action in man.
    Burns JJ
    Ann N Y Acad Sci; 1968 Jul; 151(2):959-67. PubMed ID: 4189972
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of phenobarbital on bishydroxycoumarin plasma concentrations and hypoprothrombinemic responses in sheep.
    Shetty SN; Himes JA; Edds GT
    Am J Vet Res; 1972 Apr; 33(4):825-34. PubMed ID: 4111741
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of drug metabolism by chloramphenicol.
    Christensen LK; Skovsted L
    Lancet; 1969 Dec; 2(7635):1397-9. PubMed ID: 4188280
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug interactions involving oral anticoagulants.
    O'Reilly RA
    Cardiovasc Clin; 1974; 6(2):23-41. PubMed ID: 4613460
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetics of drugs in rabbits with experimental acute renal failure.
    Van Peer A; Belpaire F; Bogaert M
    Pharmacology; 1978; 17(6):307-14. PubMed ID: 733890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of phenobarbital and SKF 525A pretreatment on diphenylhydantoin teratogenicity in mice.
    Harbison RD; Becker BA
    J Pharmacol Exp Ther; 1970 Nov; 175(2):283-8. PubMed ID: 5481698
    [No Abstract]   [Full Text] [Related]  

  • 12. IMPLICATIONS ON ENZYME INDUCTION FOR DRUG THERAPY.
    BURNS JJ
    Am J Med; 1964 Sep; 37():327-31. PubMed ID: 14218162
    [No Abstract]   [Full Text] [Related]  

  • 13. Implications of enzyme induction in drug toxicity studies.
    Welch RM; Harrison YE; Burns JJ
    Toxicol Appl Pharmacol; 1967 Mar; 10(2):340-51. PubMed ID: 4962253
    [No Abstract]   [Full Text] [Related]  

  • 14. Relationship between distribution, elimination and anticoagulant action of dicumarol.
    Jähnchen E; Levy G
    J Pharmacol Exp Ther; 1974 Feb; 188(2):293-9. PubMed ID: 4129954
    [No Abstract]   [Full Text] [Related]  

  • 15. The hydroxylation of drugs- a pharmacogenetic problem?
    Evans DA
    Proc R Soc Med; 1970 Feb; 63(2):178. PubMed ID: 4191705
    [No Abstract]   [Full Text] [Related]  

  • 16. Ultraviolet spectrophotometric analysis of barbiturates: evaluation of potential interferences.
    Jatlow P
    Am J Clin Pathol; 1973 Feb; 59(2):167-73. PubMed ID: 4119926
    [No Abstract]   [Full Text] [Related]  

  • 17. Determination of 14C-bumadizone and 14C-phenylbutazone in the systemic blood, the blood of the portal vein, the intestinal lymph and the bile of cats after intrajejunal administration.
    Seebald H; Forth W
    Arzneimittelforschung; 1977; 27(4):804-9. PubMed ID: 577456
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies of the fate of metabolites and analogs of probenecid. The significance of metabolic sites, especially lack of ring hydroxylation.
    Dayton PG; Perel JM; Cunningham RF; Israili ZH; Weiner IM
    Drug Metab Dispos; 1973; 1(6):742-51. PubMed ID: 4156295
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on the biliary excretion of 14C-dicumarol in the rat.
    Husain S; Eisenbrandt LL; Wosilait WD
    Drug Metab Dispos; 1973; 1(2):523-9. PubMed ID: 4132217
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of spironolactone and other steroids on the enzymatic decay and anticoagulant activity of bishydroxycoumarin.
    Solymoss B; Varga S; Krajny M; Werringloer J
    Thromb Diath Haemorrh; 1970 Jun; 23(3):562-8. PubMed ID: 4194159
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.